METTL3 and glioblastoma: The m6A modification may be adaptive to cellular stressors such as therapeutics, and studies have shown that m6A modification is significantly increased in temozolomide-resistant GBM cells and that temozolomide treatment induces the upregulation of METTL3, thus leading to increased m6a methylation [52,57].